Pharmacokinetics Following Single-dose of Valsartan in Japanese Pediatric Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
HypertensionChronic Kidney DiseaseNephrotic Syndrome
Interventions
DRUG

Valsartan (VAL489)

Trial Locations (2)

Unknown

Novartis Investigative Site, Aichi

Novartis Investigative Site, Tokyo

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY